Kevin Caliendo
Stock Analyst at UBS
(4.49)
# 236
Out of 4,784 analysts
170
Total ratings
68.75%
Success rate
12.29%
Average return
Main Sectors:
Stocks Rated by Kevin Caliendo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVST Envista Holdings | Maintains: Neutral | $23 → $21 | $18.03 | +16.47% | 2 | Mar 10, 2025 | |
| HSIC Henry Schein | Maintains: Neutral | $83 → $80 | $69.40 | +15.27% | 5 | Feb 26, 2025 | |
| OMI Owens & Minor | Maintains: Buy | $25 → $13 | $8.50 | +52.94% | 5 | Feb 13, 2025 | |
| MOH Molina Healthcare | Maintains: Neutral | $330 → $305 | $323.47 | -5.71% | 3 | Feb 7, 2025 | |
| CI The Cigna Group | Maintains: Buy | $410 → $390 | $324.73 | +20.10% | 11 | Feb 3, 2025 | |
| DGX Quest Diagnostics | Maintains: Neutral | $166 → $170 | $166.00 | +2.41% | 13 | Feb 3, 2025 | |
| LH Labcorp Holdings | Maintains: Buy | $293 → $286 | $231.67 | +23.45% | 2 | Jan 28, 2025 | |
| EVH Evolent Health | Maintains: Buy | $27 → $14 | $9.63 | +45.38% | 2 | Jan 16, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Buy | $35 → $27 | $15.64 | +72.63% | 9 | Dec 3, 2024 | |
| CVS CVS Health | Maintains: Neutral | $60 → $62 | $67.59 | -8.27% | 6 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $275 → $285 | $273.97 | +4.03% | 1 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $134 → $139 | $136.65 | +1.72% | 15 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $12 | $18.13 | -33.81% | 6 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $10 | $11.16 | -10.39% | 14 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $680 → $650 | $515.72 | +26.04% | 11 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $380 → $250 | $270.31 | -7.51% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $7.5 | $6.77 | +10.78% | 3 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $8.5 | $4.52 | +88.05% | 3 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $30 → $12 | $8.09 | +48.33% | 2 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $620 → $630 | $665.67 | -5.36% | 13 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $280 → $320 | $164.29 | +94.78% | 17 | Apr 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $79 | $60.23 | +31.16% | 2 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $33 → $29 | $31.25 | -7.20% | 2 | Nov 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $29 → $26 | $19.19 | +35.49% | 1 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $610 → $575 | $431.95 | +33.12% | 1 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $185 → $180 | $163.13 | +10.34% | 7 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $130 → $72 | $8.56 | +741.12% | 4 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $11 | $15.49 | -28.99% | 4 | May 4, 2021 |
Envista Holdings
Mar 10, 2025
Maintains: Neutral
Price Target: $23 → $21
Current: $18.03
Upside: +16.47%
Henry Schein
Feb 26, 2025
Maintains: Neutral
Price Target: $83 → $80
Current: $69.40
Upside: +15.27%
Owens & Minor
Feb 13, 2025
Maintains: Buy
Price Target: $25 → $13
Current: $8.50
Upside: +52.94%
Molina Healthcare
Feb 7, 2025
Maintains: Neutral
Price Target: $330 → $305
Current: $323.47
Upside: -5.71%
The Cigna Group
Feb 3, 2025
Maintains: Buy
Price Target: $410 → $390
Current: $324.73
Upside: +20.10%
Quest Diagnostics
Feb 3, 2025
Maintains: Neutral
Price Target: $166 → $170
Current: $166.00
Upside: +2.41%
Labcorp Holdings
Jan 28, 2025
Maintains: Buy
Price Target: $293 → $286
Current: $231.67
Upside: +23.45%
Evolent Health
Jan 16, 2025
Maintains: Buy
Price Target: $27 → $14
Current: $9.63
Upside: +45.38%
DENTSPLY SIRONA
Dec 3, 2024
Maintains: Buy
Price Target: $35 → $27
Current: $15.64
Upside: +72.63%
CVS Health
Nov 7, 2024
Maintains: Neutral
Price Target: $60 → $62
Current: $67.59
Upside: -8.27%
Nov 7, 2024
Maintains: Buy
Price Target: $275 → $285
Current: $273.97
Upside: +4.03%
Nov 4, 2024
Maintains: Buy
Price Target: $134 → $139
Current: $136.65
Upside: +1.72%
Oct 30, 2024
Maintains: Neutral
Price Target: $9 → $12
Current: $18.13
Upside: -33.81%
Oct 17, 2024
Maintains: Neutral
Price Target: $9 → $10
Current: $11.16
Upside: -10.39%
Oct 16, 2024
Maintains: Buy
Price Target: $680 → $650
Current: $515.72
Upside: +26.04%
Oct 4, 2024
Maintains: Neutral
Price Target: $380 → $250
Current: $270.31
Upside: -7.51%
Aug 15, 2024
Maintains: Neutral
Price Target: $9 → $7.5
Current: $6.77
Upside: +10.78%
Aug 9, 2024
Maintains: Neutral
Price Target: $9 → $8.5
Current: $4.52
Upside: +88.05%
May 23, 2024
Maintains: Neutral
Price Target: $30 → $12
Current: $8.09
Upside: +48.33%
May 8, 2024
Maintains: Buy
Price Target: $620 → $630
Current: $665.67
Upside: -5.36%
Apr 15, 2024
Maintains: Neutral
Price Target: $280 → $320
Current: $164.29
Upside: +94.78%
Dec 21, 2023
Maintains: Neutral
Price Target: $72 → $79
Current: $60.23
Upside: +31.16%
Nov 30, 2023
Maintains: Neutral
Price Target: $33 → $29
Current: $31.25
Upside: -7.20%
Aug 23, 2023
Maintains: Neutral
Price Target: $29 → $26
Current: $19.19
Upside: +35.49%
Jul 13, 2023
Maintains: Buy
Price Target: $610 → $575
Current: $431.95
Upside: +33.12%
Jul 21, 2022
Maintains: Neutral
Price Target: $185 → $180
Current: $163.13
Upside: +10.34%
Mar 8, 2022
Maintains: Neutral
Price Target: $130 → $72
Current: $8.56
Upside: +741.12%
May 4, 2021
Downgrades: Neutral
Price Target: $15 → $11
Current: $15.49
Upside: -28.99%